- Home
- LLAP vs INBX Comparison
LLAP vs INBX Comparison
Compare LLAP & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LLAP
- INBX
- Stock Information
- Founded
- LLAP 2013
- INBX 2010
- Country
- LLAP United States
- INBX United States
- Employees
- LLAP N/A
- INBX N/A
- Industry
- LLAP Military/Government/Technical
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- LLAP Industrials
- INBX Health Care
- Exchange
- LLAP Nasdaq
- INBX Nasdaq
- Market Cap
- LLAP 165.7M
- INBX 232.2M
- IPO Year
- LLAP N/A
- INBX 2020
- Fundamental
- Price
- LLAP $0.25
- INBX $15.36
- Analyst Decision
- LLAP Buy
- INBX Hold
- Analyst Count
- LLAP 3
- INBX 1
- Target Price
- LLAP $2.58
- INBX N/A
- AVG Volume (30 Days)
- LLAP 7.2M
- INBX 116.0K
- Earning Date
- LLAP 11-12-2024
- INBX 08-13-2024
- Dividend Yield
- LLAP N/A
- INBX N/A
- EPS Growth
- LLAP N/A
- INBX N/A
- EPS
- LLAP N/A
- INBX 118.83
- Revenue
- LLAP $133,107,000.00
- INBX $1,687,000.00
- Revenue This Year
- LLAP $8.71
- INBX N/A
- Revenue Next Year
- LLAP $34.59
- INBX N/A
- P/E Ratio
- LLAP N/A
- INBX $0.14
- Revenue Growth
- LLAP 10.75
- INBX 24.26
- 52 Week Low
- LLAP $0.23
- INBX $10.80
- 52 Week High
- LLAP $1.62
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- LLAP 28.11
- INBX 63.81
- Support Level
- LLAP $0.24
- INBX $14.51
- Resistance Level
- LLAP $0.27
- INBX $15.63
- Average True Range (ATR)
- LLAP 0.01
- INBX 0.72
- MACD
- LLAP 0.02
- INBX 0.09
- Stochastic Oscillator
- LLAP 25.86
- INBX 71.11
About LLAP Terran Orbital Corporation
Terran Orbital Corp is a manufacturer of satellite products primarily serving the aerospace and defense industries. The company provide end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of our military, civil, and commercial customers. Geographically company operates in United States and Europe. Majority of the revenue is generated from United States.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.